Navigation Links
Vista LifeSciences Partners with Vangard Voice Systems to Voice-Enable Medical Data Collection
Date:1/28/2010

IRVINE, Calif., Jan. 28 /PRNewswire/ -- Vangard Voice Systems, Inc. (Vangard), the innovative provider of the AccuSpeech® Mobile Voice Platform (MVP) which adds high productivity voice-direct capabilities to existing mobile applications, announced a partnership with Vista LifeSciences to voice-enable Vista LifeSciences' medical assessment and clinical encounter/medical record products. The Vangard/Vista LifeSciences partnership will initially focus on adding voice-directed data collection and application commands to Vista LifeSciences' STAT*Triage™  a robust mobile medical patient encounter tool that includes disease-specific applications, public health surveillance capabilities, and population-specific management applications (student health, home healthcare, etc.). By adding hands-free, eyes-free voice-directed commands to STAT*Triage, and other Vista LifeSciences solutions, mobile healthcare professionals will be are able to collect accurate electronic patient data at the 'point of patient care' on their mobile devices.  

(Logo:  http://www.newscom.com/cgi-bin/prnh/20090630/LA40200LOGO)

Vista LifeSciences' products are actively used by the United States Department of Defense and in clinical care in more than 50 hospitals, clinics and research organizations in North America. Vista LifeSciences' neuropsychological assessment technology has been used to collect more than 400,000 neuropsychological assessments by the U.S. Department of Defense.

Utilizing Vangard’s AccuSpeech Mobile Voice Platform to record patient information greatly improves clinical care, decreases medical errors, and leads to faster, more accurate assessments and data collection.   Chairman and Chief Operating Officer Mickey Lutz of Vista LifeSciences highlighted the importance of the partnership to offer users a technologically advanced method of data collection:  "The success of Vangard's voice products in the commercial sector illustrates the value of voice-enabled data collection. This is a phenomenal opportunity to revolutionize data collection in the medical environments.  This technology will free the hands and eyes of medical professionals and first responders to care for patients.  Clinical care will improve.  Data accuracy will improve."

"We have witnessed an amazing reception of the AccuSpeech Mobile Voice Platform into the commercial, retail and logistics sectors as people witness the increased accuracy and speed with which they can perform daily functions," said Bob Bova, President and Chief Executive Officer of Vangard Voice Systems.   "This partnership will allow us to illustrate these same benefits to the health care industry while improving the quality of care.  It is only fitting that our first efforts will be working with Vista LifeSciences to voice enable their STAT*Triage products for fast-paced triage environments where speed and accuracy are of utmost concern."

The partnership with Vangard Voice Systems will deliver highly productive and accurate voice capabilities to current and future mobile healthcare professionals working for Vista LifeSciences' public and private sector clients in clinical and triage medical settings. Using Vangard's AccuSpeech Mobile Voice Platform, medical and emergency management professionals will have "hands free" options, allowing them to greatly increase the quality of care as they assess an emergency management or triage scene and prepare initial evaluation and data collection. 

Vangard's AccuSpeech Mobile Voice Platform will also be used to supplement Vista LifeSciences' neuropsychological assessment product suite by offering a voice enabled interface to collect data from patients and care providers.  Vista LifeSciences currently provides clinical systems in the United States and Africa, and provides the Department of Defense with technology for neuropsychological assessment

About Vista LifeSciences

Vista LifeSciences (VLS) is a U.S. company dedicated to delivering better information to improve healthcare.  VLS works closely with the entire circle of healthcare providers, including clinicians, specialists, and researchers in hospital, clinic, sports, and military environments to develop and deliver information for medical treatment and decision-making. 

STAT*series™ - The Vista LifeSciences STAT*series products empower healthcare providers in remote, emergency or mobile locations to create portable patient medical records, document patient encounters, and access tailored care guidelines.  STAT*series products operate on a variety of computing platforms, and include disease-specific applications, public health surveillance capabilities, and population-specific management applications. STAT*series is scalable and can manage individual health records, manage health records for a community, or provide STAT*series healthcare records to enterprise electronic medical records system.

STAT*Triage™ is a robust mobile medical patient encounter tool that includes disease-specific applications, public health surveillance capabilities, and population-specific management applications (student health, home healthcare, etc.).

ANAM4™  - Vista LifeSciences is the exclusive distributor of ANAM4 a unique automated, flexible battery of reliable and validated assessments to measure, monitor and manage neuropsychological change from disease, trauma, and treatment.  Top military officials, disease specialists, researchers, clinicians and more than 50 hospitals have used customized ANAM4 batteries  in more than a half million neuropsychological assessments.  ANAM4 is used in wide variety of conditions including dementia, MS, Parkinson's disease and traumatic brain injury, and settings including sports medicine and environmental exposure, space travel and clinical trials.

In emergency management and readiness-to-perform applications, ANAM4 is used to assess changes in neuropsychological function due to injury, toxic or environmental exposure, and stressors including sleep deprivation.   ANAM4 baseline and follow-up assessments enable healthcare providers to identify changes in neuropsychological status that may impact safety and work performance. 

About Vangard Voice Systems

Vangard Voice Systems is the innovative provider of the AccuSpeech® Mobile Voice Platform (MVP) for enterprise-wide voice productivity deployment. MVP enables enterprises to achieve tactical, operational and strategic advantage by adding voice-directed hardware and application controls, navigation and data entry capabilities to existing mobile applications and business processes. Vangard's partners include Microsoft Corporation, Motorola, Wavelink Corporation, Stratix Corporation, Agilysys, Excalibur Integrated Systems, Z-Space Technologies and Nuance Communications.  MVP's complete device-resident voice technology is deployable on mobile devices supported by all Microsoft Mobile operating systems including Motorola, Intermec, LXE, PsionTeklogix, Opticon and others. Vangard solutions are available to government agencies on the GSA schedule and the NASA Solutions for Enterprise-Wide Procurement (SEWP) acquisition contract. For more information, visit www.vangardvoice.com.

SOURCE Vangard Voice Systems, Inc.

RELATED LINKS
http://www.vangardvoice.com

'/>"/>

SOURCE Vangard Voice Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
2. Vista Partners Initiates Coverage on Raptor Pharmaceuticals Corp.
3. Synvista Therapeutics to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
4. Vista Partners Updates Coverage on Raptor Pharmaceuticals Corp.
5. Boston Scientific Agrees To Sell Fluid Management and Venous Access Businesses to Avista Capital Partners for $425 Million
6. Avista Capital Partners Completes Acquisition of Bristol-Myers Squibb Medical Imaging
7. Accipiter Capital Management Opposes Acquisition of VistaCare, Inc. by Odyssey Healthcare, Inc.
8. Accipiter Capital Management Reaffirms Its Opposition to the Acquisition of VistaCare, Inc. by Odyssey Healthcare, Inc.
9. Boston Scientific Completes Sale of Fluid Management and Venous Access Businesses to Avista Capital Partners
10. Synvista Therapeutics to Present at the Roth 20th Annual OC Growth Stock Conference
11. Avista Capital Partners Enhances Energy Practice With Appointment of Gerhard Kurz
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... ... 2017 , ... "TransFlare 4K Mystique comes with 44 colorful mysterious transitions that ... Christina Austin - CEO of Pixel Film Studios. , TransFlare 4K Mystique contains ... lens flare and light leak transitions have a very high-dynamic range for super smooth ...
(Date:1/20/2017)... ... ... a fine examination of how God handles sin, including how to let go of ... who, for over ten long years has been waiting to release this powerful insight about ... has been serving the Lord for over twenty years, and he has been preaching and ...
(Date:1/20/2017)... , ... January 20, 2017 , ... “The Land of ... attention to the issue of world hunger, and shares the simple and achievable answer. ... devoted husband and member of the Fairview Missionary Church in Angola, Indiana where he ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... and facility enhancement of their 503A compounding pharmacy located in Ocala, Florida. ... of physicians and patients throughout the United States for high-quality human anti-aging ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... has recently unveiled impressive transportable capabilities with their iMedHD2™ Portable Teleultrasound ... extension to RMT technology that delivers HD, dynamic, streaming ultrasound images and video ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... 19, 2017 Pfizer joins ... Milner Therapeutics Consortium   Major research ... Cambridge   The Milner Therapeutics ... ) as a partner to the Milner Therapeutics Consortium. ... the efficient transfer of materials between industry and academia ...
(Date:1/19/2017)... FRANCISCO , January 19, 2017 The global  pacemaker ... new report by Grand View Research, Inc. The heightening prevalence of cardiac conditions ... the growth of Pacemaker globally. In addition, technological enhancements in these devices are ... ... Grand View Research Logo ...
(Date:1/19/2017)... , Jan. 18, 2017 The Global Therapy ... and access to partnering deals and agreements entered into ... in partnering deals - Top deals by value - ... development, technology type The report provides understanding and ... by the world,s leading healthcare companies. The report ...
Breaking Medicine Technology: